...
首页> 外文期刊>Medicinal Chemistry >QSAR Study on Pyridinone Derivatives as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor: A Mixed Approach
【24h】

QSAR Study on Pyridinone Derivatives as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor: A Mixed Approach

机译:吡啶酮衍生物作为HIV-1非核苷逆转录酶抑制剂的QSAR研究:混合方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

HIV-1 reverse transcriptase inhibitory activity of a series of substituted pyridinone derivatives (nonnucleoside) was subjected to classical QSAR study by using mixed approach (Hansch and Free-Wilson). The study was carried out with indicator parameter encoding different group contributions and some physico chemical parameters namely hydrophobic (π), electronic (), steric (MR) and STERIMOL values of aromatic substitutents. The best generated models were validated by leave-one- out technique (LOO-internal validation) and predicting the activity of the test (external validation). Further bootstrapping method was adopted to assess the robustness of the models. The analysis explores the substitutional requirements of the pyridinone moiety of the compounds for effective inhibition of HIV-1 RT enzyme.
机译:使用混合方法(Hansch和Free-Wilson)对一系列取代的吡啶酮衍生物(非核苷)的HIV-1逆转录酶抑制活性进行了经典QSAR研究。这项研究是用指示剂参数进行编码的,该指示剂参数编码了不同的基团贡献和一些物理化学参数,即芳香族取代基的疏水性(π),电子(),空间(MR)和STERIMOL值。通过留一法(LOO-内部验证)并预测测试的活动(外部验证)验证了生成最佳的模型。采用了进一步的自举方法来评估模型的鲁棒性。分析探索了化合物的吡啶酮部分对有效抑制HIV-1 RT酶的取代要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号